EUVIMEDEUVIMED entdecken
Crossref

Adjuvants to local anesthetics: efficacy, safety, and limitations

Anastasia G. Krestovnikova, Dmitry V. Zabolotskii, Victor A. Koriachkin, Ionas S. Simutis

Regional Anesthesia and Acute Pain Management · 27.02.2026 · 20 (1) · 5-15

DOI: 10.17816/ra700945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regional Anesthesia and Acute Pain Management, online erschienen am 27.02.2026. Verfasst von Anastasia G. Krestovnikova und 3 weiteren Autor:innen. Die Arbeit nennt 66 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are few options for prolonging the action of amide local anesthetics: an increase in dose and concentration is associated with a higher risk of neurotoxicity and systemic complications, whereas catheter-based techniques are resource-intensive and increase the risk of infection. No new local anesthetic molecules have been introduced since the development of levobupivacaine. Therefore, the use of adjuvants to local anesthetics is considered the most promising approach. A targeted search of publications in Russian and English was conducted in PubMed (MEDLINE) and eLibrary databases using the following keywords and their combinations: блокада периферического нерва / peripheral nerve block, местные анестетики / local anesthetics, адъювант / adjuvant, нейротоксичность / neurotoxicity, дексаметазон / dexamethasone, дексмедетомидин / dexmedetomidine. A total of 66 full-text clinical and experimental studies on perineural and/or systemic use of adjuvants in peripheral nerve and interfascial blocks were included in the analysis. The main groups of adjuvants identified were adrenergic receptor agonists, glucocorticoids, opioids, N-methyl-D-aspartate receptor antagonists magnesium salts, and benzodiazepines. A significant prolongation of sensory block and/or time to first analgesic request was demonstrated. Adverse effects were described, including hemodynamic instability associated with α2-agonists, hyperglycemia and possible delayed recovery of nerve function with dexamethasone, opioid-induced nausea and vomiting, hypermagnesemia, psychotomimetic effects of ketamine, and midazolam-related neurotoxicity. Particular attention is given to the phenomenon of rebound pain. Perineural and/or systemic administration of dexamethasone and dexmedetomidine, as well as their combination, appears to be the most justified and safe approach to prolonging block duration. However, all adjuvants except epinephrine are used perineurally off-label, which necessitates individualized risk–benefit assessment and further randomized studies, including evaluation of long-term neurotoxicity.

Zitieren

APA

Krestovnikova, A. G., Zabolotskii, D. V., Koriachkin, V. A., & Simutis, I. S. (2026). Adjuvants to local anesthetics: efficacy, safety, and limitations. Regional Anesthesia and Acute Pain Management, 20(1), 5-15. https://doi.org/10.17816/ra700945

Vancouver

Krestovnikova AG, Zabolotskii DV, Koriachkin VA, Simutis IS. Adjuvants to local anesthetics: efficacy, safety, and limitations. Regional Anesthesia and Acute Pain Management. 2026;20(1):5-15. doi:10.17816/ra700945

BibTeX
@article{Krestovnikova2026,
  author = {Krestovnikova, Anastasia G. and Zabolotskii, Dmitry V. and Koriachkin, Victor A. and Simutis, Ionas S.},
  title = {Adjuvants to local anesthetics: efficacy, safety, and limitations},
  journal = {Regional Anesthesia and Acute Pain Management},
  year = {2026},
  volume = {20},
  number = {1},
  pages = {5--15},
  doi = {10.17816/ra700945}
}
Kostenlos starten →